Tabrecta 00078-0716-94
Generic: Capmatinib
- Manufacturer
- Novartis Pharmaceuticals Corporation
- Dosage Form
- Tablet, Film Coated
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- May 6, 2020
- Listing Expires
- December 31, 2026
- Application
- NDA213591
Need to source Tabrecta? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Capmatinib Hydrochloride | 200 mg/1 |
Drug Class
Breast Cancer Resistance Protein Inhibitors [MoA]Cytochrome P450 1A2 Inhibitors [MoA]Kinase Inhibitor [EPC]
Selected Package
00078-0716-94Selected56 TABLET, FILM COATED in 1 BOTTLE (0078-0716-94)
Other packages for this product(1)
56 TABLET, FILM COATED in 1 BOTTLE (0078-0716-56)